Health Catalyst Capital

Health Catalyst Capital Management (HCCM) is a New York-based venture capital firm dedicated to investing in high-growth, US-based healthcare information technology (IT) and tech-enabled healthcare services companies. Established with a clear mission, HCCM focuses on opportunities that leverage technology to improve healthcare delivery, efficiency, and patient outcomes. The firm targets companies that have moved beyond the early startup phase, demonstrating proven business models and significant market traction.

HCCM primarily operates in the growth equity and late-stage venture segments, seeking to provide substantial capital to accelerate the expansion of its portfolio companies. Their investment strategy is characterized by a hands-on approach, where they not only provide financial backing but also offer strategic guidance, operational expertise, and access to their extensive network within the healthcare industry. They typically look for companies with established revenue streams and clear pathways to scalability, aiming to be a lead or co-lead investor in their funding rounds.

The firm has successfully raised multiple funds, underscoring its growing presence and commitment to the healthcare technology sector. For instance, Health Catalyst Capital III, LP, closed in 2021 with $200 million in committed capital, following their earlier $100 million Fund II. This consistent fundraising enables HCCM to deploy significant capital into promising ventures. While specific check sizes can vary based on the opportunity, their typical initial investment ranges from $10 million to $30 million, with the capacity for substantial follow-on investments as companies achieve key milestones and require further growth capital. Their portfolio includes notable companies such as Waystar, Cohere Health, and Clarify Health, reflecting their focus on impactful and innovative solutions within the healthcare landscape.